Search IPOs
MANIPALHOS · NSE,BSE · Healthcare Services
Manipal Health Enterprises IPO listed on 05 Aug 2026 on NSE,BSE at ₹652.00, a gain of 10.51% over the issue price of ₹590.00. The IPO was subscribed 5.12x overall.
Manipal Health Enterprises IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 29 Jul 2026 |
| IPO Close Date | 31 Jul 2026 |
| Basis of Allotment | 03 Aug 2026 |
| Initiation of Refunds | 04 Aug 2026 |
| Credit of Shares to Demat | 04 Aug 2026 |
| Listing Date | 05 Aug 2026 |
Listing day gain
+10.51%
Listed at ₹652 (issue ₹590)
Issue
₹590
Listing
₹652
Current
₹666.95
+13.04% vs issue
Day range
₹635 – ₹675.8
Issue Size
157,233,715 shares
(aggregating up to ₹9,274.00 Cr)
Issue Price
₹560 – ₹590
Face Value
₹2/share
Market Lot
25 shares
Retail Min Investment
₹14,750
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
135,619,881 shares
(aggregating up to ₹7,998 Cr)
Offer for Sale
21,613,834 shares
(aggregating up to ₹1,275 Cr)
Issue Type
book building
Open Date
29 Jul
Close Date
31 Jul
Allotment
03 Aug
Listing
05 Aug
Last updated: 2 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 02 Aug 2026 Latest | ₹590 | ₹0 | ₹590 | ₹0 |
0%
|
4:03 PM |
| 02 Aug 2026 | ₹590 | ₹0 | ₹590 | ₹0 |
0%
|
12:33 AM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 31 Jul 2026
| Category | Subscribed (x) |
|---|---|
| QIB | 8.54x |
| NII | 1.06x |
| bNII (bids above ₹10L) | 1.13x |
| sNII (bids below ₹10L) | 0.94x |
| Retail Investors | 0.98x |
| Employees | 2.32x |
| Total | 5.12x |
Showing the latest subscription snapshot.
View full subscription historyDr. Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd, Kangto Investments Pte. Ltd., Imperius Healthcare Investments Pte. Ltd., and Kabru Investments Pte. Ltd. are the promoters of the company.
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 25 | ₹14,750 |
| Retail (Max) | 13 | 325 | ₹191,750 |
| S-HNI (Min) | 14 | 350 | ₹206,500 |
| S-HNI (Max) | 67 | 1,675 | ₹988,250 |
| B-HNI (Min) | 68 | 1,700 | ₹1,003,000 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 117,714,614 (74.87%) |
|
•
Anchor Investor Shares Offered
|
70,628,768 (44.92%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
47,085,846 (29.95%) |
| NII (HNI) Shares Offered | 23,542,922 (14.97%) |
|
•
bNII > ₹10L
|
15,695,282 (9.98%) |
|
•
sNII < ₹10L
|
7,847,640 (4.99%) |
| Retail Shares Offered | 15,695,281 (9.98%) |
| Employees Shares Offered | 280,898 (0.18%) |
| Total Shares Offered | 157,233,715 (100.00%) |
Manipal Health Enterprises Limited was incorporated on February 15, 2010, and is headquartered in Bengaluru, Karnataka. It operates in the multi-specialty hospital and healthcare services sector, under the Manipal Hospitals brand.
The company runs a network of multi-specialty hospitals offering outpatient, tertiary, and quaternary healthcare services, along with pharmacy and diagnostic operations. As of September 30, 2025, it operated 38 hospitals with 10,761 licensed beds (48 hospitals with 12,367 licensed beds on a pro forma basis) across 14 states and union territories. Dr. Ranjan Ramdas Pai is a promoter of the company, along with Manipal Global Health Services, MEMG International Ltd, Kangto Investments Pte. Ltd., Imperius Healthcare Investments Pte. Ltd., and Kabru Investments Pte. Ltd. Dr. Hebri Sudarshan Ballal is Chairman and Dilip Jose Puthiyidathu is Managing Director.
On a restated basis, the company reported total income of Rs 9,409.12 crore and profit after tax of Rs 534.80 crore in FY25. The IPO is a mainboard, book-built issue comprising a fresh issue of equity shares aggregating up to Rs 8,000 crore and an offer for sale of up to 4,32,27,668 equity shares by existing shareholders, proposed for listing on the BSE and NSE. As per the DRHP, net proceeds from the fresh issue are proposed to be used for repayment or prepayment of borrowings availed by certain subsidiaries, funding the acquisition of a minority stake in Sahyadri Hospitals, and general corporate purposes.
Standalone · ₹ in Crores
| Particulars | FY Mar 2024 | FY Mar 2025 | FY Sep 2025 |
|---|---|---|---|
| Total Revenue | 6,265.17 | 9,409.12 | 5,436.31 |
| Profit After Tax (PAT) | 533.2 | 534.8 | 319.47 |
| EBITDA | 1,596.98 | - | 1,439.15 |
| Total Assets | 10,818.83 | 21,443.81 | 22,579.11 |
| Net Worth | 4,029.22 | 2,455.03 | - |
| Reserves & Surplus | - | - | - |
| Total Borrowing | - | - | - |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | Mar 2025 |
|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 26.98% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 18.16% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 5.77% |
| EBITDA Margin Earnings Before Interest, Tax, Depreciation and Amortisation Margin Profit from the main business as a share of sales, before loan interest and tax. Compare it with other companies in the same industry. | 26.65% |
| P/BV Price to Book Value Tells you if the IPO price is above what the company actually owns. 1x to 3x is usually seen as reasonable. | 11.59x |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| EPS Earnings Per Share Profit the company earns on each share. Post-IPO EPS is usually lower because the issue adds new shares. | ₹7.67 | - |
| P/E Price to Earnings Tells you if the IPO price is fair for what the company earns. Compare it with listed companies in the same sector. | 76.52x | - |
| Market Cap Market Capitalisation What the whole company is valued at, at the upper price band. Post-IPO counts the new shares the issue creates. | ₹69,606 Cr | ₹9,275 Cr |
The basis of allotment for Manipal Health Enterprises IPO was finalised on 03 Aug 2026. You can check your allotment status using your PAN number or application number on the KFin Technologies Limited portal or BSE.
The Manipal Health Enterprises IPO is expected to open in Jul 2026, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Manipal Health Enterprises IPO is ₹560.00 - ₹590.00 per share.
As per market sources, Manipal Health Enterprises IPO GMP is currently ₹0.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Manipal Health Enterprises IPO stands at 5.12x overall.
The listing date for Manipal Health Enterprises IPO is 05 Aug 2026.
No comments yet. Be the first to comment!
